nodes	percent_of_prediction	percent_of_DWPC	metapath
Epoprostenol—systemic scleroderma—Nifedipine—hypertension	0.219	1	CpDpCtD
Epoprostenol—Treprostinil—Nadolol—hypertension	0.191	1	CrCrCtD
Epoprostenol—PTGIS—hypertension	0.188	0.608	CbGaD
Epoprostenol—PTGIR—hypertension	0.121	0.392	CbGaD
Epoprostenol—CYP2C9—Eprosartan—hypertension	0.0123	0.125	CbGbCtD
Epoprostenol—CYP2C9—Torasemide—hypertension	0.01	0.102	CbGbCtD
Epoprostenol—CYP2C9—Guanfacine—hypertension	0.0093	0.0951	CbGbCtD
Epoprostenol—CYP2C9—Candesartan—hypertension	0.0093	0.0951	CbGbCtD
Epoprostenol—CYP2C9—Diltiazem—hypertension	0.00705	0.0721	CbGbCtD
Epoprostenol—CYP2C9—Valsartan—hypertension	0.00645	0.0659	CbGbCtD
Epoprostenol—CYP2C9—Irbesartan—hypertension	0.00575	0.0587	CbGbCtD
Epoprostenol—CYP2C9—Amlodipine—hypertension	0.00563	0.0576	CbGbCtD
Epoprostenol—CYP2C9—Felodipine—hypertension	0.00543	0.0556	CbGbCtD
Epoprostenol—CYP2C9—Nifedipine—hypertension	0.00525	0.0537	CbGbCtD
Epoprostenol—CYP2C9—Nicardipine—hypertension	0.00517	0.0529	CbGbCtD
Epoprostenol—CYP2C9—Carvedilol—hypertension	0.00517	0.0529	CbGbCtD
Epoprostenol—CYP2C9—Atorvastatin—hypertension	0.00405	0.0414	CbGbCtD
Epoprostenol—CYP2C9—Losartan—hypertension	0.0037	0.0379	CbGbCtD
Epoprostenol—CYP2C9—Verapamil—hypertension	0.00327	0.0334	CbGbCtD
Epoprostenol—PTGIR—pulmonary artery—hypertension	0.00312	0.122	CbGeAlD
Epoprostenol—PTGIS—artery—hypertension	0.00202	0.0787	CbGeAlD
Epoprostenol—P2RY12—artery—hypertension	0.00182	0.0709	CbGeAlD
Epoprostenol—PTGIS—endothelium—hypertension	0.0017	0.0665	CbGeAlD
Epoprostenol—PTGIS—blood vessel—hypertension	0.00157	0.0613	CbGeAlD
Epoprostenol—PTGIR—artery—hypertension	0.00116	0.0452	CbGeAlD
Epoprostenol—PTGIS—myocardium—hypertension	0.00106	0.0415	CbGeAlD
Epoprostenol—PTGIR—endothelium—hypertension	0.000978	0.0382	CbGeAlD
Epoprostenol—PTGIR—blood vessel—hypertension	0.000902	0.0352	CbGeAlD
Epoprostenol—Treprostinil—PTGIR—hypertension	0.000869	0.415	CrCbGaD
Epoprostenol—PTGIS—heart—hypertension	0.000743	0.029	CbGeAlD
Epoprostenol—PTGIS—smooth muscle tissue—hypertension	0.000737	0.0288	CbGeAlD
Epoprostenol—PTGIS—decidua—hypertension	0.000722	0.0282	CbGeAlD
Epoprostenol—PTGIS—cardiovascular system—hypertension	0.000701	0.0274	CbGeAlD
Epoprostenol—PTGER1—kidney—hypertension	0.000637	0.0249	CbGeAlD
Epoprostenol—P2RY12—cardiovascular system—hypertension	0.000631	0.0246	CbGeAlD
Epoprostenol—CYP2C9—urine—hypertension	0.000595	0.0232	CbGeAlD
Epoprostenol—PTGIS—adrenal gland—hypertension	0.000554	0.0216	CbGeAlD
Epoprostenol—PTGIR—brainstem—hypertension	0.000493	0.0193	CbGeAlD
Epoprostenol—PTGIS—endocrine gland—hypertension	0.000481	0.0188	CbGeAlD
Epoprostenol—PTGER1—endocrine gland—hypertension	0.000447	0.0174	CbGeAlD
Epoprostenol—Alprostadil—PTGIR—hypertension	0.000445	0.212	CrCbGaD
Epoprostenol—PTGIS—central nervous system—hypertension	0.000433	0.0169	CbGeAlD
Epoprostenol—P2RY12—endocrine gland—hypertension	0.000433	0.0169	CbGeAlD
Epoprostenol—PTGIR—heart—hypertension	0.000427	0.0167	CbGeAlD
Epoprostenol—PTGIR—smooth muscle tissue—hypertension	0.000423	0.0165	CbGeAlD
Epoprostenol—PTGER1—central nervous system—hypertension	0.000403	0.0157	CbGeAlD
Epoprostenol—PTGIR—cardiovascular system—hypertension	0.000402	0.0157	CbGeAlD
Epoprostenol—PTGIR—kidney—hypertension	0.000394	0.0154	CbGeAlD
Epoprostenol—P2RY12—central nervous system—hypertension	0.00039	0.0152	CbGeAlD
Epoprostenol—Dinoprost Tromethamine—PTGIR—hypertension	0.000355	0.17	CrCbGaD
Epoprostenol—PTGIR—adrenal gland—hypertension	0.000318	0.0124	CbGeAlD
Epoprostenol—PTGIR—endocrine gland—hypertension	0.000276	0.0108	CbGeAlD
Epoprostenol—Dinoprostone—PTGIR—hypertension	0.000273	0.131	CrCbGaD
Epoprostenol—PTGIR—central nervous system—hypertension	0.000249	0.00971	CbGeAlD
Epoprostenol—CYP2C9—heart—hypertension	0.000152	0.00595	CbGeAlD
Epoprostenol—CYP2C9—cardiovascular system—hypertension	0.000144	0.00561	CbGeAlD
Epoprostenol—Dinoprostone—CYP11A1—hypertension	9.95e-05	0.0476	CrCbGaD
Epoprostenol—CYP2C9—endocrine gland—hypertension	9.87e-05	0.00385	CbGeAlD
Epoprostenol—Dinoprostone—CYP19A1—hypertension	5.15e-05	0.0246	CrCbGaD
Epoprostenol—Dermatitis—Nifedipine—hypertension	1.23e-05	0.000134	CcSEcCtD
Epoprostenol—Abdominal pain—Irbesartan—hypertension	1.23e-05	0.000134	CcSEcCtD
Epoprostenol—Body temperature increased—Irbesartan—hypertension	1.23e-05	0.000134	CcSEcCtD
Epoprostenol—Thrombocytopenia—Ramipril—hypertension	1.23e-05	0.000134	CcSEcCtD
Epoprostenol—Oedema—Timolol—hypertension	1.23e-05	0.000134	CcSEcCtD
Epoprostenol—Anaphylactic shock—Timolol—hypertension	1.23e-05	0.000134	CcSEcCtD
Epoprostenol—Loss of consciousness—Lisinopril—hypertension	1.23e-05	0.000133	CcSEcCtD
Epoprostenol—Rash—Verapamil—hypertension	1.23e-05	0.000133	CcSEcCtD
Epoprostenol—Urticaria—Hydrochlorothiazide—hypertension	1.23e-05	0.000133	CcSEcCtD
Epoprostenol—Tachycardia—Ramipril—hypertension	1.23e-05	0.000133	CcSEcCtD
Epoprostenol—Dermatitis—Verapamil—hypertension	1.23e-05	0.000133	CcSEcCtD
Epoprostenol—Headache—Nifedipine—hypertension	1.22e-05	0.000133	CcSEcCtD
Epoprostenol—Pruritus—Clonidine—hypertension	1.22e-05	0.000133	CcSEcCtD
Epoprostenol—Body temperature increased—Hydrochlorothiazide—hypertension	1.22e-05	0.000133	CcSEcCtD
Epoprostenol—Abdominal pain—Hydrochlorothiazide—hypertension	1.22e-05	0.000133	CcSEcCtD
Epoprostenol—Skin disorder—Ramipril—hypertension	1.22e-05	0.000133	CcSEcCtD
Epoprostenol—Infection—Timolol—hypertension	1.22e-05	0.000133	CcSEcCtD
Epoprostenol—Headache—Verapamil—hypertension	1.22e-05	0.000133	CcSEcCtD
Epoprostenol—Hypersensitivity—Telmisartan—hypertension	1.22e-05	0.000133	CcSEcCtD
Epoprostenol—Cough—Lisinopril—hypertension	1.22e-05	0.000132	CcSEcCtD
Epoprostenol—Nausea—Diltiazem—hypertension	1.22e-05	0.000132	CcSEcCtD
Epoprostenol—Nausea—Indapamide—hypertension	1.22e-05	0.000132	CcSEcCtD
Epoprostenol—Hyperhidrosis—Ramipril—hypertension	1.21e-05	0.000132	CcSEcCtD
Epoprostenol—Asthenia—Trandolapril—hypertension	1.21e-05	0.000131	CcSEcCtD
Epoprostenol—Shock—Timolol—hypertension	1.21e-05	0.000131	CcSEcCtD
Epoprostenol—Urticaria—Furosemide—hypertension	1.21e-05	0.000131	CcSEcCtD
Epoprostenol—Nervous system disorder—Timolol—hypertension	1.2e-05	0.000131	CcSEcCtD
Epoprostenol—Nausea—Carvedilol—hypertension	1.2e-05	0.000131	CcSEcCtD
Epoprostenol—Asthenia—Enalapril—hypertension	1.2e-05	0.000131	CcSEcCtD
Epoprostenol—Body temperature increased—Furosemide—hypertension	1.2e-05	0.000131	CcSEcCtD
Epoprostenol—Abdominal pain—Furosemide—hypertension	1.2e-05	0.000131	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Losartan—hypertension	1.2e-05	0.00013	CcSEcCtD
Epoprostenol—Dizziness—Valsartan—hypertension	1.2e-05	0.00013	CcSEcCtD
Epoprostenol—Anorexia—Ramipril—hypertension	1.2e-05	0.00013	CcSEcCtD
Epoprostenol—Urticaria—Betaxolol—hypertension	1.19e-05	0.00013	CcSEcCtD
Epoprostenol—Skin disorder—Timolol—hypertension	1.19e-05	0.00013	CcSEcCtD
Epoprostenol—Dizziness—Olmesartan—hypertension	1.19e-05	0.00013	CcSEcCtD
Epoprostenol—Pruritus—Trandolapril—hypertension	1.19e-05	0.00013	CcSEcCtD
Epoprostenol—Nausea—Doxazosin—hypertension	1.19e-05	0.000129	CcSEcCtD
Epoprostenol—Chest pain—Lisinopril—hypertension	1.19e-05	0.000129	CcSEcCtD
Epoprostenol—Myalgia—Lisinopril—hypertension	1.19e-05	0.000129	CcSEcCtD
Epoprostenol—Arthralgia—Lisinopril—hypertension	1.19e-05	0.000129	CcSEcCtD
Epoprostenol—Body temperature increased—Betaxolol—hypertension	1.19e-05	0.000129	CcSEcCtD
Epoprostenol—Hyperhidrosis—Timolol—hypertension	1.19e-05	0.000129	CcSEcCtD
Epoprostenol—Asthenia—Telmisartan—hypertension	1.19e-05	0.000129	CcSEcCtD
Epoprostenol—Pruritus—Enalapril—hypertension	1.19e-05	0.000129	CcSEcCtD
Epoprostenol—Anxiety—Lisinopril—hypertension	1.18e-05	0.000129	CcSEcCtD
Epoprostenol—Diarrhoea—Clonidine—hypertension	1.18e-05	0.000128	CcSEcCtD
Epoprostenol—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—hypertension	1.18e-05	0.000128	CcSEcCtD
Epoprostenol—Nausea—Fosinopril—hypertension	1.18e-05	0.000128	CcSEcCtD
Epoprostenol—Hypotension—Ramipril—hypertension	1.17e-05	0.000128	CcSEcCtD
Epoprostenol—Anorexia—Timolol—hypertension	1.17e-05	0.000127	CcSEcCtD
Epoprostenol—Pruritus—Telmisartan—hypertension	1.17e-05	0.000127	CcSEcCtD
Epoprostenol—Nausea—Eplerenone—hypertension	1.17e-05	0.000127	CcSEcCtD
Epoprostenol—Urticaria—Losartan—hypertension	1.16e-05	0.000127	CcSEcCtD
Epoprostenol—Dry mouth—Lisinopril—hypertension	1.16e-05	0.000126	CcSEcCtD
Epoprostenol—Nausea—Nifedipine—hypertension	1.16e-05	0.000126	CcSEcCtD
Epoprostenol—Abdominal pain—Losartan—hypertension	1.16e-05	0.000126	CcSEcCtD
Epoprostenol—Body temperature increased—Losartan—hypertension	1.16e-05	0.000126	CcSEcCtD
Epoprostenol—Nausea—Verapamil—hypertension	1.16e-05	0.000126	CcSEcCtD
Epoprostenol—Asthenia—Captopril—hypertension	1.15e-05	0.000125	CcSEcCtD
Epoprostenol—Diarrhoea—Trandolapril—hypertension	1.15e-05	0.000125	CcSEcCtD
Epoprostenol—Vomiting—Valsartan—hypertension	1.15e-05	0.000125	CcSEcCtD
Epoprostenol—Confusional state—Lisinopril—hypertension	1.15e-05	0.000125	CcSEcCtD
Epoprostenol—Diarrhoea—Enalapril—hypertension	1.15e-05	0.000125	CcSEcCtD
Epoprostenol—Hypotension—Timolol—hypertension	1.15e-05	0.000125	CcSEcCtD
Epoprostenol—Hypersensitivity—Irbesartan—hypertension	1.15e-05	0.000125	CcSEcCtD
Epoprostenol—Vomiting—Olmesartan—hypertension	1.15e-05	0.000125	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Ramipril—hypertension	1.14e-05	0.000124	CcSEcCtD
Epoprostenol—Rash—Valsartan—hypertension	1.14e-05	0.000124	CcSEcCtD
Epoprostenol—Dizziness—Clonidine—hypertension	1.14e-05	0.000124	CcSEcCtD
Epoprostenol—Dermatitis—Valsartan—hypertension	1.14e-05	0.000124	CcSEcCtD
Epoprostenol—Oedema—Lisinopril—hypertension	1.14e-05	0.000124	CcSEcCtD
Epoprostenol—Anaphylactic shock—Lisinopril—hypertension	1.14e-05	0.000124	CcSEcCtD
Epoprostenol—Pruritus—Captopril—hypertension	1.14e-05	0.000124	CcSEcCtD
Epoprostenol—Hypersensitivity—Hydrochlorothiazide—hypertension	1.14e-05	0.000124	CcSEcCtD
Epoprostenol—Rash—Olmesartan—hypertension	1.14e-05	0.000124	CcSEcCtD
Epoprostenol—Insomnia—Ramipril—hypertension	1.14e-05	0.000124	CcSEcCtD
Epoprostenol—Dermatitis—Olmesartan—hypertension	1.14e-05	0.000123	CcSEcCtD
Epoprostenol—Headache—Valsartan—hypertension	1.13e-05	0.000123	CcSEcCtD
Epoprostenol—Diarrhoea—Telmisartan—hypertension	1.13e-05	0.000123	CcSEcCtD
Epoprostenol—Infection—Lisinopril—hypertension	1.13e-05	0.000123	CcSEcCtD
Epoprostenol—Headache—Olmesartan—hypertension	1.13e-05	0.000123	CcSEcCtD
Epoprostenol—Paraesthesia—Ramipril—hypertension	1.13e-05	0.000123	CcSEcCtD
Epoprostenol—Shock—Lisinopril—hypertension	1.12e-05	0.000122	CcSEcCtD
Epoprostenol—Asthenia—Perindopril—hypertension	1.12e-05	0.000122	CcSEcCtD
Epoprostenol—Dyspnoea—Ramipril—hypertension	1.12e-05	0.000122	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Timolol—hypertension	1.12e-05	0.000122	CcSEcCtD
Epoprostenol—Hypersensitivity—Furosemide—hypertension	1.12e-05	0.000122	CcSEcCtD
Epoprostenol—Asthenia—Irbesartan—hypertension	1.12e-05	0.000121	CcSEcCtD
Epoprostenol—Somnolence—Ramipril—hypertension	1.12e-05	0.000121	CcSEcCtD
Epoprostenol—Thrombocytopenia—Lisinopril—hypertension	1.12e-05	0.000121	CcSEcCtD
Epoprostenol—Dizziness—Trandolapril—hypertension	1.11e-05	0.000121	CcSEcCtD
Epoprostenol—Tachycardia—Lisinopril—hypertension	1.11e-05	0.000121	CcSEcCtD
Epoprostenol—Insomnia—Timolol—hypertension	1.11e-05	0.000121	CcSEcCtD
Epoprostenol—Dizziness—Enalapril—hypertension	1.11e-05	0.000121	CcSEcCtD
Epoprostenol—Asthenia—Hydrochlorothiazide—hypertension	1.11e-05	0.00012	CcSEcCtD
Epoprostenol—Hypersensitivity—Betaxolol—hypertension	1.11e-05	0.00012	CcSEcCtD
Epoprostenol—Skin disorder—Lisinopril—hypertension	1.11e-05	0.00012	CcSEcCtD
Epoprostenol—Dyspepsia—Ramipril—hypertension	1.11e-05	0.00012	CcSEcCtD
Epoprostenol—Pruritus—Perindopril—hypertension	1.11e-05	0.00012	CcSEcCtD
Epoprostenol—Paraesthesia—Timolol—hypertension	1.1e-05	0.00012	CcSEcCtD
Epoprostenol—Pruritus—Irbesartan—hypertension	1.1e-05	0.00012	CcSEcCtD
Epoprostenol—Hyperhidrosis—Lisinopril—hypertension	1.1e-05	0.00012	CcSEcCtD
Epoprostenol—Diarrhoea—Captopril—hypertension	1.1e-05	0.00012	CcSEcCtD
Epoprostenol—Vomiting—Clonidine—hypertension	1.1e-05	0.000119	CcSEcCtD
Epoprostenol—Dyspnoea—Timolol—hypertension	1.1e-05	0.000119	CcSEcCtD
Epoprostenol—Dizziness—Telmisartan—hypertension	1.09e-05	0.000119	CcSEcCtD
Epoprostenol—Pruritus—Hydrochlorothiazide—hypertension	1.09e-05	0.000119	CcSEcCtD
Epoprostenol—Decreased appetite—Ramipril—hypertension	1.09e-05	0.000119	CcSEcCtD
Epoprostenol—Somnolence—Timolol—hypertension	1.09e-05	0.000119	CcSEcCtD
Epoprostenol—Asthenia—Furosemide—hypertension	1.09e-05	0.000118	CcSEcCtD
Epoprostenol—Rash—Clonidine—hypertension	1.09e-05	0.000118	CcSEcCtD
Epoprostenol—Dermatitis—Clonidine—hypertension	1.09e-05	0.000118	CcSEcCtD
Epoprostenol—Anorexia—Lisinopril—hypertension	1.09e-05	0.000118	CcSEcCtD
Epoprostenol—Gastrointestinal disorder—Ramipril—hypertension	1.08e-05	0.000118	CcSEcCtD
Epoprostenol—Fatigue—Ramipril—hypertension	1.08e-05	0.000118	CcSEcCtD
Epoprostenol—Headache—Clonidine—hypertension	1.08e-05	0.000118	CcSEcCtD
Epoprostenol—Dyspepsia—Timolol—hypertension	1.08e-05	0.000118	CcSEcCtD
Epoprostenol—Hypersensitivity—Losartan—hypertension	1.08e-05	0.000117	CcSEcCtD
Epoprostenol—Asthenia—Betaxolol—hypertension	1.08e-05	0.000117	CcSEcCtD
Epoprostenol—Nausea—Valsartan—hypertension	1.08e-05	0.000117	CcSEcCtD
Epoprostenol—Pruritus—Furosemide—hypertension	1.07e-05	0.000117	CcSEcCtD
Epoprostenol—Constipation—Ramipril—hypertension	1.07e-05	0.000117	CcSEcCtD
Epoprostenol—Nausea—Olmesartan—hypertension	1.07e-05	0.000116	CcSEcCtD
Epoprostenol—Vomiting—Trandolapril—hypertension	1.07e-05	0.000116	CcSEcCtD
Epoprostenol—Diarrhoea—Perindopril—hypertension	1.07e-05	0.000116	CcSEcCtD
Epoprostenol—Decreased appetite—Timolol—hypertension	1.07e-05	0.000116	CcSEcCtD
Epoprostenol—Vomiting—Enalapril—hypertension	1.07e-05	0.000116	CcSEcCtD
Epoprostenol—Diarrhoea—Irbesartan—hypertension	1.07e-05	0.000116	CcSEcCtD
Epoprostenol—Hypotension—Lisinopril—hypertension	1.06e-05	0.000116	CcSEcCtD
Epoprostenol—Dizziness—Captopril—hypertension	1.06e-05	0.000116	CcSEcCtD
Epoprostenol—Pruritus—Betaxolol—hypertension	1.06e-05	0.000116	CcSEcCtD
Epoprostenol—Rash—Trandolapril—hypertension	1.06e-05	0.000115	CcSEcCtD
Epoprostenol—Dermatitis—Trandolapril—hypertension	1.06e-05	0.000115	CcSEcCtD
Epoprostenol—Gastrointestinal disorder—Timolol—hypertension	1.06e-05	0.000115	CcSEcCtD
Epoprostenol—Fatigue—Timolol—hypertension	1.06e-05	0.000115	CcSEcCtD
Epoprostenol—Rash—Enalapril—hypertension	1.06e-05	0.000115	CcSEcCtD
Epoprostenol—Dermatitis—Enalapril—hypertension	1.06e-05	0.000115	CcSEcCtD
Epoprostenol—Diarrhoea—Hydrochlorothiazide—hypertension	1.06e-05	0.000115	CcSEcCtD
Epoprostenol—Headache—Trandolapril—hypertension	1.06e-05	0.000115	CcSEcCtD
Epoprostenol—Vomiting—Telmisartan—hypertension	1.05e-05	0.000114	CcSEcCtD
Epoprostenol—Asthenia—Losartan—hypertension	1.05e-05	0.000114	CcSEcCtD
Epoprostenol—Headache—Enalapril—hypertension	1.05e-05	0.000114	CcSEcCtD
Epoprostenol—Pain—Timolol—hypertension	1.05e-05	0.000114	CcSEcCtD
Epoprostenol—Rash—Telmisartan—hypertension	1.04e-05	0.000113	CcSEcCtD
Epoprostenol—Dermatitis—Telmisartan—hypertension	1.04e-05	0.000113	CcSEcCtD
Epoprostenol—Diarrhoea—Furosemide—hypertension	1.04e-05	0.000113	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Lisinopril—hypertension	1.04e-05	0.000113	CcSEcCtD
Epoprostenol—Pruritus—Losartan—hypertension	1.04e-05	0.000113	CcSEcCtD
Epoprostenol—Headache—Telmisartan—hypertension	1.04e-05	0.000113	CcSEcCtD
Epoprostenol—Dizziness—Perindopril—hypertension	1.03e-05	0.000112	CcSEcCtD
Epoprostenol—Insomnia—Lisinopril—hypertension	1.03e-05	0.000112	CcSEcCtD
Epoprostenol—Dizziness—Irbesartan—hypertension	1.03e-05	0.000112	CcSEcCtD
Epoprostenol—Diarrhoea—Betaxolol—hypertension	1.03e-05	0.000112	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Ramipril—hypertension	1.03e-05	0.000112	CcSEcCtD
Epoprostenol—Nausea—Clonidine—hypertension	1.03e-05	0.000112	CcSEcCtD
Epoprostenol—Paraesthesia—Lisinopril—hypertension	1.02e-05	0.000111	CcSEcCtD
Epoprostenol—Vomiting—Captopril—hypertension	1.02e-05	0.000111	CcSEcCtD
Epoprostenol—Dizziness—Hydrochlorothiazide—hypertension	1.02e-05	0.000111	CcSEcCtD
Epoprostenol—Dyspnoea—Lisinopril—hypertension	1.02e-05	0.00011	CcSEcCtD
Epoprostenol—Rash—Captopril—hypertension	1.01e-05	0.00011	CcSEcCtD
Epoprostenol—Dermatitis—Captopril—hypertension	1.01e-05	0.00011	CcSEcCtD
Epoprostenol—Somnolence—Lisinopril—hypertension	1.01e-05	0.00011	CcSEcCtD
Epoprostenol—Headache—Captopril—hypertension	1.01e-05	0.00011	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Timolol—hypertension	1e-05	0.000109	CcSEcCtD
Epoprostenol—Dizziness—Furosemide—hypertension	1e-05	0.000109	CcSEcCtD
Epoprostenol—Dyspepsia—Lisinopril—hypertension	1e-05	0.000109	CcSEcCtD
Epoprostenol—Diarrhoea—Losartan—hypertension	1e-05	0.000109	CcSEcCtD
Epoprostenol—Nausea—Trandolapril—hypertension	1e-05	0.000109	CcSEcCtD
Epoprostenol—Urticaria—Ramipril—hypertension	9.98e-06	0.000109	CcSEcCtD
Epoprostenol—Nausea—Enalapril—hypertension	9.96e-06	0.000108	CcSEcCtD
Epoprostenol—Dizziness—Betaxolol—hypertension	9.94e-06	0.000108	CcSEcCtD
Epoprostenol—Vomiting—Perindopril—hypertension	9.93e-06	0.000108	CcSEcCtD
Epoprostenol—Abdominal pain—Ramipril—hypertension	9.93e-06	0.000108	CcSEcCtD
Epoprostenol—Body temperature increased—Ramipril—hypertension	9.93e-06	0.000108	CcSEcCtD
Epoprostenol—Decreased appetite—Lisinopril—hypertension	9.9e-06	0.000108	CcSEcCtD
Epoprostenol—Vomiting—Irbesartan—hypertension	9.9e-06	0.000108	CcSEcCtD
Epoprostenol—Rash—Perindopril—hypertension	9.85e-06	0.000107	CcSEcCtD
Epoprostenol—Dermatitis—Perindopril—hypertension	9.84e-06	0.000107	CcSEcCtD
Epoprostenol—Gastrointestinal disorder—Lisinopril—hypertension	9.84e-06	0.000107	CcSEcCtD
Epoprostenol—Nausea—Telmisartan—hypertension	9.83e-06	0.000107	CcSEcCtD
Epoprostenol—Fatigue—Lisinopril—hypertension	9.82e-06	0.000107	CcSEcCtD
Epoprostenol—Vomiting—Hydrochlorothiazide—hypertension	9.82e-06	0.000107	CcSEcCtD
Epoprostenol—Rash—Irbesartan—hypertension	9.82e-06	0.000107	CcSEcCtD
Epoprostenol—Dermatitis—Irbesartan—hypertension	9.81e-06	0.000107	CcSEcCtD
Epoprostenol—Headache—Perindopril—hypertension	9.79e-06	0.000106	CcSEcCtD
Epoprostenol—Urticaria—Timolol—hypertension	9.76e-06	0.000106	CcSEcCtD
Epoprostenol—Headache—Irbesartan—hypertension	9.75e-06	0.000106	CcSEcCtD
Epoprostenol—Constipation—Lisinopril—hypertension	9.74e-06	0.000106	CcSEcCtD
Epoprostenol—Pain—Lisinopril—hypertension	9.74e-06	0.000106	CcSEcCtD
Epoprostenol—Rash—Hydrochlorothiazide—hypertension	9.74e-06	0.000106	CcSEcCtD
Epoprostenol—Dermatitis—Hydrochlorothiazide—hypertension	9.73e-06	0.000106	CcSEcCtD
Epoprostenol—Body temperature increased—Timolol—hypertension	9.71e-06	0.000106	CcSEcCtD
Epoprostenol—Abdominal pain—Timolol—hypertension	9.71e-06	0.000106	CcSEcCtD
Epoprostenol—Dizziness—Losartan—hypertension	9.69e-06	0.000105	CcSEcCtD
Epoprostenol—Headache—Hydrochlorothiazide—hypertension	9.67e-06	0.000105	CcSEcCtD
Epoprostenol—Vomiting—Furosemide—hypertension	9.66e-06	0.000105	CcSEcCtD
Epoprostenol—Rash—Furosemide—hypertension	9.58e-06	0.000104	CcSEcCtD
Epoprostenol—Dermatitis—Furosemide—hypertension	9.57e-06	0.000104	CcSEcCtD
Epoprostenol—Vomiting—Betaxolol—hypertension	9.56e-06	0.000104	CcSEcCtD
Epoprostenol—Nausea—Captopril—hypertension	9.56e-06	0.000104	CcSEcCtD
Epoprostenol—Headache—Furosemide—hypertension	9.51e-06	0.000103	CcSEcCtD
Epoprostenol—Rash—Betaxolol—hypertension	9.48e-06	0.000103	CcSEcCtD
Epoprostenol—Dermatitis—Betaxolol—hypertension	9.47e-06	0.000103	CcSEcCtD
Epoprostenol—Headache—Betaxolol—hypertension	9.42e-06	0.000102	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Lisinopril—hypertension	9.32e-06	0.000101	CcSEcCtD
Epoprostenol—Vomiting—Losartan—hypertension	9.32e-06	0.000101	CcSEcCtD
Epoprostenol—Nausea—Perindopril—hypertension	9.28e-06	0.000101	CcSEcCtD
Epoprostenol—Hypersensitivity—Ramipril—hypertension	9.26e-06	0.000101	CcSEcCtD
Epoprostenol—Nausea—Irbesartan—hypertension	9.25e-06	0.000101	CcSEcCtD
Epoprostenol—Rash—Losartan—hypertension	9.24e-06	0.0001	CcSEcCtD
Epoprostenol—Dermatitis—Losartan—hypertension	9.23e-06	0.0001	CcSEcCtD
Epoprostenol—Headache—Losartan—hypertension	9.18e-06	9.98e-05	CcSEcCtD
Epoprostenol—Nausea—Hydrochlorothiazide—hypertension	9.17e-06	9.97e-05	CcSEcCtD
Epoprostenol—Urticaria—Lisinopril—hypertension	9.05e-06	9.84e-05	CcSEcCtD
Epoprostenol—Hypersensitivity—Timolol—hypertension	9.05e-06	9.84e-05	CcSEcCtD
Epoprostenol—Nausea—Furosemide—hypertension	9.02e-06	9.81e-05	CcSEcCtD
Epoprostenol—Asthenia—Ramipril—hypertension	9.01e-06	9.8e-05	CcSEcCtD
Epoprostenol—Abdominal pain—Lisinopril—hypertension	9.01e-06	9.79e-05	CcSEcCtD
Epoprostenol—Body temperature increased—Lisinopril—hypertension	9.01e-06	9.79e-05	CcSEcCtD
Epoprostenol—Nausea—Betaxolol—hypertension	8.93e-06	9.71e-05	CcSEcCtD
Epoprostenol—Pruritus—Ramipril—hypertension	8.89e-06	9.66e-05	CcSEcCtD
Epoprostenol—Asthenia—Timolol—hypertension	8.81e-06	9.58e-05	CcSEcCtD
Epoprostenol—Nausea—Losartan—hypertension	8.7e-06	9.46e-05	CcSEcCtD
Epoprostenol—Pruritus—Timolol—hypertension	8.69e-06	9.45e-05	CcSEcCtD
Epoprostenol—Diarrhoea—Ramipril—hypertension	8.6e-06	9.35e-05	CcSEcCtD
Epoprostenol—Diarrhoea—Timolol—hypertension	8.4e-06	9.14e-05	CcSEcCtD
Epoprostenol—Hypersensitivity—Lisinopril—hypertension	8.39e-06	9.13e-05	CcSEcCtD
Epoprostenol—Dizziness—Ramipril—hypertension	8.31e-06	9.03e-05	CcSEcCtD
Epoprostenol—Asthenia—Lisinopril—hypertension	8.18e-06	8.89e-05	CcSEcCtD
Epoprostenol—Dizziness—Timolol—hypertension	8.12e-06	8.83e-05	CcSEcCtD
Epoprostenol—Pruritus—Lisinopril—hypertension	8.06e-06	8.76e-05	CcSEcCtD
Epoprostenol—Vomiting—Ramipril—hypertension	7.99e-06	8.68e-05	CcSEcCtD
Epoprostenol—Rash—Ramipril—hypertension	7.92e-06	8.61e-05	CcSEcCtD
Epoprostenol—Dermatitis—Ramipril—hypertension	7.91e-06	8.6e-05	CcSEcCtD
Epoprostenol—Headache—Ramipril—hypertension	7.87e-06	8.56e-05	CcSEcCtD
Epoprostenol—Vomiting—Timolol—hypertension	7.81e-06	8.49e-05	CcSEcCtD
Epoprostenol—Diarrhoea—Lisinopril—hypertension	7.8e-06	8.48e-05	CcSEcCtD
Epoprostenol—Rash—Timolol—hypertension	7.74e-06	8.42e-05	CcSEcCtD
Epoprostenol—Dermatitis—Timolol—hypertension	7.74e-06	8.41e-05	CcSEcCtD
Epoprostenol—Headache—Timolol—hypertension	7.69e-06	8.37e-05	CcSEcCtD
Epoprostenol—Dizziness—Lisinopril—hypertension	7.53e-06	8.19e-05	CcSEcCtD
Epoprostenol—Nausea—Ramipril—hypertension	7.46e-06	8.11e-05	CcSEcCtD
Epoprostenol—Nausea—Timolol—hypertension	7.3e-06	7.93e-05	CcSEcCtD
Epoprostenol—Vomiting—Lisinopril—hypertension	7.24e-06	7.88e-05	CcSEcCtD
Epoprostenol—Rash—Lisinopril—hypertension	7.18e-06	7.81e-05	CcSEcCtD
Epoprostenol—Dermatitis—Lisinopril—hypertension	7.18e-06	7.8e-05	CcSEcCtD
Epoprostenol—Headache—Lisinopril—hypertension	7.14e-06	7.76e-05	CcSEcCtD
Epoprostenol—Nausea—Lisinopril—hypertension	6.77e-06	7.36e-05	CcSEcCtD
Epoprostenol—CYP2C9—Metabolism—CYP11B1—hypertension	2.54e-06	3.99e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—FGFR1—hypertension	2.53e-06	3.98e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—FGFR1—hypertension	2.53e-06	3.98e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—FN1—hypertension	2.49e-06	3.92e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—PRKCB—hypertension	2.49e-06	3.92e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—F2—hypertension	2.49e-06	3.92e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—HIF1A—hypertension	2.49e-06	3.92e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—HIF1A—hypertension	2.49e-06	3.92e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—AGT—hypertension	2.48e-06	3.91e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—AGT—hypertension	2.48e-06	3.91e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—hypertension	2.48e-06	3.9e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—AKT1—hypertension	2.47e-06	3.89e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—hypertension	2.46e-06	3.87e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—GBA—hypertension	2.45e-06	3.86e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—EPHX2—hypertension	2.45e-06	3.86e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—GSTM5—hypertension	2.45e-06	3.86e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ALOX12—hypertension	2.45e-06	3.86e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—DBH—hypertension	2.45e-06	3.86e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CALM1—hypertension	2.44e-06	3.84e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CALM1—hypertension	2.44e-06	3.84e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—NOTCH1—hypertension	2.44e-06	3.84e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—LEP—hypertension	2.43e-06	3.83e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—APOE—hypertension	2.43e-06	3.83e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—LEP—hypertension	2.43e-06	3.83e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—APOE—hypertension	2.43e-06	3.83e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CAV1—hypertension	2.41e-06	3.79e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CAV1—hypertension	2.41e-06	3.79e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—APOA1—hypertension	2.4e-06	3.78e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—APOA1—hypertension	2.4e-06	3.78e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—KDR—hypertension	2.38e-06	3.75e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—KDR—hypertension	2.38e-06	3.75e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CYP2J2—hypertension	2.38e-06	3.74e-05	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—PTEN—hypertension	2.38e-06	3.74e-05	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—MYC—hypertension	2.36e-06	3.71e-05	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—TGFB1—hypertension	2.35e-06	3.7e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—GLS2—hypertension	2.31e-06	3.63e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—COX5B—hypertension	2.31e-06	3.63e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ARG1—hypertension	2.31e-06	3.63e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—DECR1—hypertension	2.31e-06	3.63e-05	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—EGFR—hypertension	2.31e-06	3.63e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—PRKCB—hypertension	2.29e-06	3.61e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—F2—hypertension	2.29e-06	3.61e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—FN1—hypertension	2.29e-06	3.61e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—F2—hypertension	2.29e-06	3.61e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—PRKCB—hypertension	2.29e-06	3.61e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—FN1—hypertension	2.29e-06	3.61e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—POMC—hypertension	2.27e-06	3.57e-05	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—EP300—hypertension	2.27e-06	3.56e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—INS—hypertension	2.26e-06	3.55e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—NOTCH1—hypertension	2.25e-06	3.53e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—NOTCH1—hypertension	2.25e-06	3.53e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CCL2—hypertension	2.22e-06	3.49e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ALAD—hypertension	2.19e-06	3.44e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—IGF1—hypertension	2.18e-06	3.44e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—AKT2—hypertension	2.18e-06	3.43e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—EGFR—hypertension	2.17e-06	3.42e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—POMC—hypertension	2.09e-06	3.29e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—POMC—hypertension	2.09e-06	3.29e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—STS—hypertension	2.09e-06	3.28e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PLCE1—hypertension	2.09e-06	3.28e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ALDH7A1—hypertension	2.09e-06	3.28e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—INS—hypertension	2.08e-06	3.27e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—INS—hypertension	2.08e-06	3.27e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—SERPINE1—hypertension	2.07e-06	3.26e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—hypertension	2.06e-06	3.24e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CCL2—hypertension	2.04e-06	3.22e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CCL2—hypertension	2.04e-06	3.22e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—IGF1—hypertension	2.01e-06	3.16e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—IGF1—hypertension	2.01e-06	3.16e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—AKT2—hypertension	2.01e-06	3.16e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—AKT2—hypertension	2.01e-06	3.16e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—FGF2—hypertension	2.01e-06	3.16e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—RHOA—hypertension	2e-06	3.15e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—EGFR—hypertension	2e-06	3.15e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—EGFR—hypertension	2e-06	3.15e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CYP4A11—hypertension	2e-06	3.15e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CBS—hypertension	2e-06	3.15e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ARG2—hypertension	2e-06	3.15e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—PIK3R1—hypertension	1.98e-06	3.11e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—NOS3—hypertension	1.98e-06	3.11e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—XDH—hypertension	1.96e-06	3.08e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CYP3A5—hypertension	1.92e-06	3.03e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PTGIS—hypertension	1.92e-06	3.03e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—SLC5A2—hypertension	1.92e-06	3.03e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—SERPINE1—hypertension	1.91e-06	3e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—SERPINE1—hypertension	1.91e-06	3e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—hypertension	1.89e-06	2.97e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—RELA—hypertension	1.86e-06	2.93e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—TPH1—hypertension	1.86e-06	2.92e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ABCC1—hypertension	1.86e-06	2.92e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—UCP3—hypertension	1.86e-06	2.92e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—HSD11B1—hypertension	1.86e-06	2.92e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—UCP2—hypertension	1.86e-06	2.92e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—FGF2—hypertension	1.85e-06	2.91e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—FGF2—hypertension	1.85e-06	2.91e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—RHOA—hypertension	1.84e-06	2.9e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—RHOA—hypertension	1.84e-06	2.9e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—MTOR—hypertension	1.83e-06	2.88e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—NOS3—hypertension	1.82e-06	2.87e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—NOS3—hypertension	1.82e-06	2.87e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—PIK3R1—hypertension	1.82e-06	2.87e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—PIK3R1—hypertension	1.82e-06	2.87e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—APOB—hypertension	1.8e-06	2.83e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—SLC2A3—hypertension	1.8e-06	2.83e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ALAS1—hypertension	1.8e-06	2.83e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CYP11B2—hypertension	1.8e-06	2.83e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—HSD3B1—hypertension	1.77e-06	2.79e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ADA—hypertension	1.77e-06	2.79e-05	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—IL6—hypertension	1.77e-06	2.79e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CXCL8—hypertension	1.76e-06	2.76e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—FADS1—hypertension	1.75e-06	2.75e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—AQP1—hypertension	1.75e-06	2.75e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—LPL—hypertension	1.72e-06	2.71e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—RELA—hypertension	1.72e-06	2.7e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—RELA—hypertension	1.72e-06	2.7e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—TBXAS1—hypertension	1.7e-06	2.67e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CA9—hypertension	1.7e-06	2.67e-05	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—AKT1—hypertension	1.7e-06	2.67e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—MTOR—hypertension	1.68e-06	2.65e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—MTOR—hypertension	1.68e-06	2.65e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—hypertension	1.68e-06	2.64e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—IL6—hypertension	1.67e-06	2.63e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—hypertension	1.66e-06	2.61e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ALOX15—hypertension	1.66e-06	2.61e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ALOX5AP—hypertension	1.66e-06	2.61e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—CD36—hypertension	1.63e-06	2.57e-05	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—AKT1—hypertension	1.63e-06	2.57e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—LHB—hypertension	1.62e-06	2.54e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—HADHA—hypertension	1.62e-06	2.54e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CXCL8—hypertension	1.62e-06	2.54e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CXCL8—hypertension	1.62e-06	2.54e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—MMP9—hypertension	1.59e-06	2.5e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CDKN1A—hypertension	1.58e-06	2.49e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—KCNJ11—hypertension	1.58e-06	2.49e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—LPA—hypertension	1.58e-06	2.49e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—HSD3B2—hypertension	1.58e-06	2.49e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—PTEN—hypertension	1.58e-06	2.48e-05	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—AKT1—hypertension	1.56e-06	2.46e-05	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—AKT1—hypertension	1.56e-06	2.46e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—MAPK8—hypertension	1.55e-06	2.43e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—AKT1—hypertension	1.54e-06	2.42e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—IL6—hypertension	1.54e-06	2.42e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—IL6—hypertension	1.54e-06	2.42e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—hypertension	1.52e-06	2.39e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CYP2C18—hypertension	1.52e-06	2.38e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—LRP2—hypertension	1.52e-06	2.38e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—EP300—hypertension	1.51e-06	2.37e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—AGT—hypertension	1.47e-06	2.32e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—SRC—hypertension	1.46e-06	2.3e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—MMP9—hypertension	1.46e-06	2.3e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—MMP9—hypertension	1.46e-06	2.3e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—HSPG2—hypertension	1.46e-06	2.29e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CDKN1A—hypertension	1.46e-06	2.29e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CDKN1A—hypertension	1.46e-06	2.29e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—PTEN—hypertension	1.45e-06	2.29e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—PTEN—hypertension	1.45e-06	2.29e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—APOE—hypertension	1.44e-06	2.27e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—hypertension	1.43e-06	2.25e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—VEGFA—hypertension	1.43e-06	2.24e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—hypertension	1.43e-06	2.24e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—MAPK8—hypertension	1.42e-06	2.24e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—MAPK8—hypertension	1.42e-06	2.24e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—AKT1—hypertension	1.42e-06	2.23e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—AKT1—hypertension	1.42e-06	2.23e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ALOX5—hypertension	1.41e-06	2.22e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—GLP1R—hypertension	1.41e-06	2.22e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—EP300—hypertension	1.39e-06	2.18e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—EP300—hypertension	1.39e-06	2.18e-05	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—AKT1—hypertension	1.37e-06	2.15e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—SRC—hypertension	1.35e-06	2.12e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—SRC—hypertension	1.35e-06	2.12e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—VEGFA—hypertension	1.31e-06	2.07e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—VEGFA—hypertension	1.31e-06	2.07e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—MYC—hypertension	1.31e-06	2.06e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—TGFB1—hypertension	1.31e-06	2.06e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ALDH2—hypertension	1.29e-06	2.03e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—EGFR—hypertension	1.28e-06	2.02e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—hypertension	1.26e-06	1.98e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—HBA1—hypertension	1.26e-06	1.97e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CYP11A1—hypertension	1.25e-06	1.96e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—POMC—hypertension	1.24e-06	1.95e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—GSTT1—hypertension	1.23e-06	1.93e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—SLC9A1—hypertension	1.23e-06	1.93e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CETP—hypertension	1.21e-06	1.91e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—GCLC—hypertension	1.21e-06	1.91e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—MYC—hypertension	1.21e-06	1.9e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—MYC—hypertension	1.21e-06	1.9e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—TGFB1—hypertension	1.21e-06	1.9e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—TGFB1—hypertension	1.21e-06	1.9e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—EGFR—hypertension	1.18e-06	1.86e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—EGFR—hypertension	1.18e-06	1.86e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CYP17A1—hypertension	1.16e-06	1.82e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PTGS1—hypertension	1.15e-06	1.81e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ENO1—hypertension	1.15e-06	1.81e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hypertension	1.13e-06	1.78e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CTGF—hypertension	1.11e-06	1.74e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—HMGCR—hypertension	1.1e-06	1.72e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—GOT2—hypertension	1.1e-06	1.72e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hypertension	1.08e-06	1.7e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—TP53—hypertension	1.08e-06	1.7e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ADRA2A—hypertension	1.07e-06	1.69e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—TH—hypertension	1e-06	1.58e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CALM2—hypertension	1e-06	1.57e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—TP53—hypertension	9.92e-07	1.56e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—TP53—hypertension	9.92e-07	1.56e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—hypertension	9.88e-07	1.55e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—IL6—hypertension	9.87e-07	1.55e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—GCG—hypertension	9.77e-07	1.54e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—SLC2A4—hypertension	9.77e-07	1.54e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—GOT1—hypertension	9.46e-07	1.49e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—STK11—hypertension	9.18e-07	1.44e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CYP19A1—hypertension	9.18e-07	1.44e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—AKT1—hypertension	9.1e-07	1.43e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—IL6—hypertension	9.08e-07	1.43e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—IL6—hypertension	9.08e-07	1.43e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hypertension	8.62e-07	1.36e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—COMT—hypertension	8.54e-07	1.34e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PPARGC1A—hypertension	8.42e-07	1.32e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—GNB3—hypertension	8.42e-07	1.32e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—HMOX1—hypertension	8.38e-07	1.32e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—AKT1—hypertension	8.38e-07	1.32e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—AKT1—hypertension	8.38e-07	1.32e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CAT—hypertension	8.27e-07	1.3e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hypertension	8.22e-07	1.29e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—GNAS—hypertension	8.2e-07	1.29e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—APOB—hypertension	8.03e-07	1.26e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—GSTM1—hypertension	7.81e-07	1.23e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—LPL—hypertension	7.66e-07	1.21e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ADCY5—hypertension	7.5e-07	1.18e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—GPX1—hypertension	7.48e-07	1.18e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PRKCA—hypertension	7.4e-07	1.16e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CYP1A1—hypertension	7.4e-07	1.16e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CD36—hypertension	7.28e-07	1.15e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—MTHFR—hypertension	6.9e-07	1.09e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PPARA—hypertension	6.77e-07	1.06e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—AGT—hypertension	6.56e-07	1.03e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CALM1—hypertension	6.45e-07	1.01e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—APOE—hypertension	6.42e-07	1.01e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CAV1—hypertension	6.36e-07	1e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—APOA1—hypertension	6.35e-07	9.99e-06	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PPARG—hypertension	5.59e-07	8.8e-06	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—POMC—hypertension	5.52e-07	8.68e-06	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—INS—hypertension	5.49e-07	8.63e-06	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ALB—hypertension	5.03e-07	7.91e-06	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PIK3R1—hypertension	4.81e-07	7.57e-06	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—NOS3—hypertension	4.81e-07	7.57e-06	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PTGS2—hypertension	4.4e-07	6.92e-06	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PTEN—hypertension	3.84e-07	6.04e-06	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—EP300—hypertension	3.66e-07	5.76e-06	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—AKT1—hypertension	2.21e-07	3.48e-06	CbGpPWpGaD
